Pimavanserin: Side Effects, Uses & Monitoring

Facts extracted from current FDA product labeling for Pimavanserin. Educational only — not medical advice.

Labeled uses

NUPLAZID® is indicated for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis [ see Clinical Studies (14) ] .

Source: FDA labeling via NIH DailyMed (set 1e6bea44…). Not affiliated with FDA or NIH.

Medical disclaimer: Always consult a qualified healthcare professional about any medication.

Ratings summarize government-reported measures — they don't capture your personal needs. Visit the facility, ask about staffing and services, and use CMS checklists. This profile is informational only and is not a recommendation.